Evidence map›Paper›PMID 37738109›Full record

ArticleEuropean journal of microbiology & immunology2023

Design and optimization of an improved qPCR assay for the detection of Histoplasma capsulatum.

Bianca Kelly Neves Izidro da Silva, Ana Cláudia Alves Cortez, Luciana Aires Oliveira, Juan Diego Ribeiro de Almeida, Érica Simplício de Souza, Katia Santana Cruz, Ani Beatriz Jackisch Matsuura, Mauricio Morishi Ogusku, Karolina Jeaneth Solórzano Chavarría, Djane Baía-da-Silva and 4 more

Abstract read
In one paragraph

Article in European journal of microbiology & immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Histoplasmosis in HIV/AIDS patients in Amazonas, Northern Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bianca Kelly Neves Izidro da Silva1Graduate Program in Pharmaceutical Sciences, Universidade Federal do Amazonas-UFAM, Manaus, Brazil.
Ana Cláudia Alves Cortez2Mycology Laboratory, Instituto Nacional de Pesquisas da Amazonia-INPA, Manaus, Brazil.
Luciana Aires Oliveira2Mycology Laboratory, Instituto Nacional de Pesquisas da Amazonia-INPA, Manaus, Brazil.
Juan Diego Ribeiro de Almeida2Mycology Laboratory, Instituto Nacional de Pesquisas da Amazonia-INPA, Manaus, Brazil.
Érica Simplício de Souza3Superior School of Technology, Universidade do Estado do Amazonas -UEA, Manaus, Brazil.
Katia Santana Cruz4Medical Mycology Laboratory, Fundação de Medicina Tropical Doutor Heitor Vieira Dourado-FMT-HVD, Manaus, Brazil.
Ani Beatriz Jackisch Matsuura5Microbial Diversity Laboratory of the Amazon with Health Importance, Leônidas and Maria Deane Institute-Fiocruz-AM, Manaus, Amazonas, Brazil.
Mauricio Morishi Ogusku6Mycobacteriology Laboratory, Instituto Nacional de Pesquisas da Amazonia-INPA, Manaus, Brazil.
Karolina Jeaneth Solórzano Chavarría7Graduate Program in Tropical Medicine, Fundação de Medicina Tropical Doutor Heitor Vieira Dourado-FMT-HVD, Manaus, Brazil.
Djane Baía-da-Silva1Graduate Program in Pharmaceutical Sciences, Universidade Federal do Amazonas-UFAM, Manaus, Brazil.
Quique Bassat11ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Marcus Vinícius Guimarães Lacerda7Graduate Program in Tropical Medicine, Fundação de Medicina Tropical Doutor Heitor Vieira Dourado-FMT-HVD, Manaus, Brazil.
Hagen Frickmann16Institute for Medical Microbiology, Virology and Hygiene, University Medicine Rostock, Rostock, Germany.
João Vicente Braga de Souza2Mycology Laboratory, Instituto Nacional de Pesquisas da Amazonia-INPA, Manaus, Brazil.ORCID 0000-0002-3163-7499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aimed at improving a real-time polymerase-chain-reaction (qPCR) assay for the detection of Histoplasma capsulatum, a fungal pathogen that can cause severe respiratory infections in humans, in clinical and soil samples. Methods: Primer and probes were in-silico designed, in-silico and in-vitro evaluated including clinical biopsy materials and finally subjected to a real-world application with collected soil samples. Results: Applying the qPCR assay with liver and lung biopsies from 71 patients each, including 59 patients infected with human immunodeficiency virus (HIV), as well as with Sabouraud (SAB) agar culture as the diagnostic reference standard, diagnostic accuracy of the qPCR assay of 100% (5/5) sensitivity and 96% (63/66) specificity for liver samples and 100% (4/4) sensitivity and 94% (63/67) specificity for the lung samples was recorded. When applying the assay with soil samples from caves near of Presidente Figueiredo city, Amazonas, Brazil, one sample from the Maroaga cave was confirmed as positive. Conclusions: The improved qPCR assessed in this study was successful in detecting H. capsulatum with high efficiency and accuracy in in-vitro evaluation, including the identification of the target pathogen in both clinical and environmental samples.

Indexed as

biopsyHistoplasma capsulatumin-silico evaluationin-vitro evaluationPresidente Figueiredo cavesqPCRsensitivitysoilspecificity

Identifiers

PMID37738109
PMCPMC10578137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.